Xenetic Biosciences XBIO
NASDAQ XBIO
$2.32 +0.06 (+2.65%)
At close: Sep 30, 2026 · 4:00 PM EDT

Xenetic Biosciences (XBIO) Short term Debt (2013 - 2016)

Updated

Xenetic Biosciences' Short term Debt was $1.14 million in Q3 2016, down 59.7% from $2.81 million a year earlier.

Analysis

Xenetic Biosciences (XBIO) Short term Debt (2013 - 2016) Analysis & Trends

At the end of FY2015, Short term Debt at Xenetic Biosciences came in at $3.65 million.

  • In earlier years, Short term Debt was $212,813 in FY2013.
  • The Q3 2016 figure marks the lowest quarterly Short term Debt since Q4 2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Xenetic Biosciences 5.44 Mn -20.39 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2016 1.14 Mn
Mar 31, 2016 7.00 Mn
Dec 31, 2015 3.65 Mn
Sep 30, 2015 2.81 Mn
Nov 30, 2013 372,813.00
Aug 31, 2013 212,813.00
API Access

Xenetic Biosciences Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=XBIO&period=max&api_key=YOUR_API_KEY